Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Longke Biotechnology is a synthetic biology company based in Suzhou, China, specializing in enzyme engineering and biocatalysis. The company leverages high-throughput screening and directed evolution platforms to develop high-performance enzymes for the pharmaceutical, chemical, and food industries. Their core business involves providing green chemistry solutions and enzymatic synthesis processes for pharmaceutical intermediates and active pharmaceutical ingredients (APIs). By replacing traditional chemical synthesis with enzymatic routes, Longke Bio aims to reduce production costs and environmental impact for its partners. The company's technology platform supports the development of sustainable manufacturing processes across the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Longke Biotechnology.